Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, through its Investment Bank & Global Wealth Management division, has reported a disposal of voting rights in Renalytix PLC, resulting in their holding falling below the 5% reporting threshold. As of October 1, 2026, UBS Group AG's total voting rights in Renalytix PLC are 0.000000%, a decrease from their previous notification where they held 5.958468%. This change is due to UBS trading book holdings falling below the reporting threshold, making them exempt from further reporting.

Disclaimer*

UK 100

Latest directors dealings